-
1دورية أكاديمية
المؤلفون: Kandolf Sekulovic Lidija, Peris K, Hauschild Axel, Stratigos Alexander John, Grob Jean Jacque, Nathan Paul, Dummer Reinhard, Forsea Ana Maria, Hoeller Christoph, Gogas Helen, Demidov Lev, Lebbe Celeste, Blank Christian, Olah Judit, Bastholt Lars, Herceg H, Neyns Bart, Vieira Ricardo, Hansson Johan, Rutkowski Piotr, Krajsova Ivana, Bylaite-Bucinskiene Matilda, Zalaudek Iris, Marić-Brozić Jasmina, Babović Nada, Banjin Maja, Putnik Kadri, Weinlich Georg, Todorović Vladimir, Kirov K, Ocvirk Janja, Kukushkina M, De la Cruz Merino Luis, Ymeri A, Risteski Milan, Garbe Claus
المصدر: Eur J Cancer 75(April) 313-322
مصطلحات موضوعية: Access, Innovative medicines, Metastatic melanoma, Treatment Immunooncology, Targeted therapy Health, Health expenditure per capita, Human development index
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28264791; https://zenodo.org/communities/iorsTest; https://zenodo.org/record/3727132Test; https://doi.org/10.1016/j.ejca.2017.01.012Test; oai:zenodo.org:3727132
-
2
المؤلفون: Ketty Peris, Lev V. Demidov, Lars Bastholt, J.-J. Grob, Paul Nathan, M. Banjin, M. Kukushkina, Alexandros Stratigos, A.M. Forsea, A. Ymeri, Matilda Bylaite-Bucinskiene, Christoph Hoeller, A. Zhukavets, V. Todorovic, G. Weinlich, Claus Garbe, K. Putnik, L. Kandolf Sekulovic, Piotr Rutkowski, M. Risteski, K. Kirov, Iris Zalaudek, J. Ocvirk, Reinhard Dummer, D. Herceg, J. Maric-Brozic, Helen Gogas, Ricardo Vieira, Judit Oláh, Ivana Krajsová, N. Babovic, L. De La Cruz Merino, C. Blank, Johan Hansson, Bart Neyns, Axel Hauschild, C. Lebbé
المساهمون: Laboratory of Molecullar and Cellular Therapy, Laboratory for Medical and Molecular Oncology, Clinical sciences, [Sekulovic, L. Kandolf] Mil Med Acad, Fac Med, Dept Dermatol, Belgrade, Serbia, [Peris, K.] Univ Cattolica Sacro Cuore, Inst Dermatol, Rome, Italy, [Hauschild, A.] Univ Hosp Schleswig Holstein UKSH, Dept Dermatol, Campus Kiel, Kiel, Germany, [Stratigos, A.] Univ Athens, Athens, Greece, [Gogas, H.] Univ Athens, Athens, Greece, [Grob, J. -J.] Hop la Timone, Serv Dermatol & Cancerol Cutanee, Marseille, France, [Nathan, P.] Mt Vernon Canc Ctr, Northwood, Middx, England, [Dummer, R.] Univ Hosp, Univ Spital Zurich, Skin Canc Ctr, Zurich, Switzerland, [Forsea, A. -M.] Carol Davila Univ Med & Pharm, Elias Univ Hosp Bucharest, Bucharest, Romania, [Hoeller, C.] Med Univ Vienna, Dept Dermatol, Vienna, Austria, [Demidov, L.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia, [Lebbe, C.] Hosp St Louis, APHP, Paris, France, [Blank, C.] Netherland Canc Inst, Amsterdam, Netherlands, [Olah, J.] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary, [Bastholt, L.] Odense Univ Hosp, Dept Oncol, Odense, Denmark, [Herceg, D.] Univ Hosp Zagreb, Dept Oncol, Zagreb, Croatia, [Neyns, B.] VUB, Univ Ziekenhuis Brussel, Dept Med Oncol, Brussels, Belgium, [Vieira, R.] Univ Coimbra, Fac Med, Dept Dermatol, Coimbra, Portugal, [Hansson, J.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden, [Hansson, J.] Karolinska Univ Hosp Solna, Stockholm, Sweden, [Rutkowski, P.] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland, [Rutkowski, P.] Inst Oncol, Warsaw, Poland, [Krajsova, I.] Gen Teaching Hosp, Prague, Czech Republic, [Bylaite-Bucinskiene, M.] Vilnius Univ, Dept Dermatol, Vilnius, Lithuania, [Zalaudek, I.] Med Univ Graz, Div Dermatol & Venerol, Graz, Austria, [Maric-Brozic, J.] Univ Hosp Ctr Sestre Milosrdnice, Zagreb, Croatia, [Babovic, N.] Inst Oncol & Radiol Serbia, Belgrade, Serbia, [Banjin, M.] Univ Hosp Sarajevo, Dept Oncol, Sarajevo, Bosnia & Herceg, [Putnik, K.] North Estonia Med Ctr, Tallinn, Estonia, [Weinlich, G.] Med Univ Innsbruck, Dept Dermatol & Venerol & Allergy, Innsbruck, Austria, [Todorovic, V.] Clin Oncol & Radiotherapy, Podgorica, Montenegro, [Kirov, K.] Natl Canc Ctr, Clin Oncodermatol, Sofia, Bulgaria, [Ocvirk, J.] Inst Oncol Ljubljana, Ljubljana, Slovenia, [Zhukavets, A.] NN Alexandrov Natl Canc Ctr Belarus NCCB, Minsk, BELARUS, [Kukushkina, M.] Natl Canc Inst, Kiev, Ukraine, [De La Cruz Merino, L.] Hosp Univ Virgen Macarena, Dept Clin Oncol, Seville, Spain, [Ymeri, A.] Univ Hosp Mother Theresa, Tirana, Albania, [Risteski, M.] Univ Clin Radiotherapy & Oncol, Skopje, Macedonia, [Garbe, C.] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany, Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.
المصدر: Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J J, Nathan, P, Dummer, R, Forsea, A M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, G K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M & Garbe, C 2017, ' More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments ', European Journal of Cancer, vol. 75, pp. 313-322 . https://doi.org/10.1016/j.ejca.2017.01.012Test
مصطلحات موضوعية: Human development index, Male, Cancer Research, Skin Neoplasms, Survival, medicine.medical_treatment, Access, Health expenditure per capita, Immunooncology, Innovative medicines, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compounds, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparities, Humans, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanisms, Therapies, Investigational, Oncology, Investigational, Reimbursement Mechanism, Melanoma/economics, Disparities, Immuno oncology, Medicines, 0302 clinical medicine, Diagnosis, Health care, Monoclonal, 030212 general & internal medicine, Healthcare Disparities/economics, Acce, Acrylonitrile/analogs & derivatives, Humanized, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Reimbursement, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Aniline Compound, Healthcare Disparitie, Health Services Accessibility/economics, 030220 oncology & carcinogenesis, Targeted therapy Health, Innovative medicine, Health-care, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Treatment Immunooncology, Human, medicine.medical_specialty, Reimbursement Mechanisms/statistics & numerical data, Union, Antibodies, Europe/epidemiology, Malignant-melanoma, 03 medical and health sciences, Pharmacotherapy, Internal medicine, medicine, Skin Neoplasm, Human Development Index, Mortality, Therapies, Investigational/economics, Skin Neoplasms/economics, Health policy, business.industry, Cancer, medicine.disease, access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index, Surgery, Immunotherapy/economics, Therapies, Aniline Compounds/economics, Skin cancer, business, Cancer incidence, Antibodies, Monoclonal, Humanized/economics
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f963ef44b2ff1f7ae62a81d631ae3c4Test
https://portal.findresearcher.sdu.dk/da/publications/08a9e901-9c2e-4d58-beae-d673d2edee93Test